This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Keith Christopher Knight: Innovator in Pharmaceutical Research
Introduction: Keith Christopher Knight is a notable inventor based in Parma, Italy. He is currently associated with Chiesi Farmaceutici S.p.a., where he contributes to advancements in pharmaceutical research. Although he has not yet been granted any patents, his work is focused on developing innovative compounds that may have significant therapeutic applications.
Latest Patent Applications: Keith has been involved in several recent patent applications. One of his notable applications is for Tetrahydrothieno pyridine derivatives as DDR inhibitors. This invention relates to compounds that inhibit Discoidin Domain Receptors (DDR), methods for preparing these compounds, and their pharmaceutical compositions. These compounds may be useful in treating various disorders associated with DDR mechanisms. Another application is for Indoline derivatives as DDR inhibitors, which shares similar characteristics and potential therapeutic uses.
Conclusion: Keith Christopher Knight is an emerging inventor in the pharmaceutical field, working on innovative solutions that may lead to significant advancements in medical treatments. His contributions, although not yet reflected in granted patents, show promise for future developments in the industry.